federal_register: 2022-23033

All Federal Register documents (rules, proposed rules, notices, presidential documents) from 1994 to present. Nearly 1M documents with full-text search.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

document_number title type abstract publication_date pub_year pub_month html_url pdf_url agency_names agency_ids excerpts
2022-23033 Nonprescription Drug Product With an Additional Condition for Nonprescription Use; Extension of Comment Period Proposed Rule The Food and Drug Administration (FDA or the Agency) is extending the comment period for the proposed rule that appeared in the Federal Register of June 28, 2022. The Agency is taking this action in response to requests for an extension to allow interested persons additional time to submit comments. 2022-10-24 2022 10 https://www.federalregister.gov/documents/2022/10/24/2022-23033/nonprescription-drug-product-with-an-additional-condition-for-nonprescription-use-extension-of https://www.govinfo.gov/content/pkg/FR-2022-10-24/pdf/2022-23033.pdf Health and Human Services Department; Food and Drug Administration 221,199 The Food and Drug Administration (FDA or the Agency) is extending the comment period for the proposed rule that appeared in the Federal Register of June 28, 2022. The Agency is taking this action in response to requests for an extension to allow...

Links from other tables